Skip to the page

Data / Form D filings / Progentos Therapeutics, Inc.

Progentos Therapeutics, Inc.: Form D filing

Progentos Therapeutics, Inc., a company in Watertown, MA, filed a Form D with the SEC in 2024. The latest, on May 17, 2024, reports $68.6 million sold of a $68.6 million offering to 39 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
200 DEXTER AVENUE, Watertown, MA, 02472
Phone
(857) 363-0218
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2014427

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 17, 2024New notice$68,588,739$68,588,73939May 3, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Aleks Radovic-MorenoDirector
Dmitrij HristodorovDirector
Dan JanneyDirector
Christopher LooseExecutive Officer, Director
Cassidy BlundellDirector
Sanjay MagaviExecutive Officer
Marc-Olivier TurgeonDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of May 13, 2024 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Progentos Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.